Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
Browsing: data
Alnylam falls after full data for heart drug that can rival Pfizer’s Source: Seekingalpha
Alnylam tumbles, BridgeBio gains after heart drug data Source: Seekingalpha
Alnylam falls after full data for heart drug that can rival Pfizer’s Source: Seekingalpha
Alnylam tumbles, BridgeBio gains after heart drug data Source: Seekingalpha
Alnylam falls after full data for heart drug that can rival Pfizer’s Source: Seekingalpha
Alnylam tumbles, BridgeBio gains after heart drug data Source: Seekingalpha
Gain slips after early-stage data for Parkinson’s therapy Source: Seekingalpha
Krystal Biotech’s Jeune reports promising phase 1 data on wrinkles drug Source: (*1*)
Invivyd down 18% despite Pemgarda COVID risk reduction data Source: Seekingalpha